Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 11, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

Immunotherapy for advanced melanoma: Current knowledge and future directions.

Kenta Nakamura1, Ryuhei Okuyama1

  • 1Department of Dermatology, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano 390-8621, Japan.

Journal of Dermatological Science
|June 16, 2016
PubMed
Summary

Immunotherapy has advanced melanoma treatment by activating cytotoxic T lymphocytes (CTLs). Patient immune status is key for effective melanoma immunotherapy, with tailored and combination therapies on the horizon.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circumferential strain recovery after human cardiomyocyte transplantation in minipigs using a novel frequency-based method for myocardial tagging quantification.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2026
Same author

Intracranial efficacy of combined immune checkpoint inhibitors and platinum plus etoposide therapy in patients with extensive-disease small-cell lung cancer and brain metastases.

Cancer treatment and research communications·2026
Same author

An Exploratory Study to Identify Factors Associated with Recurrence of Generalized Pustular Psoriasis Flares in Adult Patients in Japan.

Acta dermato-venereologica·2026
Same author

Complications and Laboratory Test Findings Among Patients With Generalized Pustular Psoriasis: A Retrospective Chart Review Study.

Experimental dermatology·2026
Same author

Extramammary Paget's Disease With Concomitant Syphilis Mimicking Multifocal Involvement.

The Journal of dermatology·2026
Same author

Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.

The Journal of dermatology·2025

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Melanoma is an aggressive skin cancer with high mortality.
  • Immunotherapy has emerged as a significant advancement in melanoma treatment.
  • Tumor-specific neo-antigens on melanoma cells facilitate immunotherapy via cytotoxic T lymphocyte (CTL) activation.

Purpose of the Study:

  • To review current immunotherapeutic approaches for melanoma.
  • To discuss the mechanisms of action for various immunotherapies.
  • To highlight future directions in melanoma immunotherapy.

Main Methods:

  • Review of recent literature on melanoma immunotherapy.
  • Analysis of approved immunotherapies and ongoing clinical trials.
  • Discussion of immunotherapy mechanisms including CTL activation and tumor microenvironment modification.
Keywords:
Immune checkpointImmunotherapyMelanomaNeo-antigenT cell transfer therapy

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.5K

Related Experiment Videos

Last Updated: Jan 11, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.5K

Main Results:

  • Immunotherapy efficacy in melanoma is dependent on patient immune status.
  • Approved immunotherapies function through diverse mechanisms like CTL brake release and activation.
  • Ongoing research focuses on patient-tailored and combination therapies.

Conclusions:

  • Immunotherapy offers promising therapeutic effects for melanoma.
  • Monitoring patient immune status is crucial for selecting optimal immunotherapy.
  • Future melanoma treatment will likely involve personalized and combination immunotherapy strategies.